Understanding Peptide Purity: What ≥99% Really Means for Research

The Reality of Peptide Purity

Two certificates of analysis (COA) can both report 99% purity and describe fundamentally different materials. Purity is not a single, absolute number; it is a relative measurement derived from a specific analytical method, on a specific instrument, and expressed against a defined baseline. Understanding these nuances is the difference between an assay that yields reproducible data and one that introduces variables every time you open a new vial.

How Peptide Purity is Actually Measured

Nearly every supplier quotes HPLC purity, which represents the percentage area of the target peak on a reversed-phase chromatogram, typically detected at 214 nm or 220 nm where the peptide bond absorbs. This method separates components based on hydrophobicity: your target elutes at a characteristic retention time, and everything else absorbing at that wavelength is counted as an impurity.

Area percentage is a relative measurement. It does not account for non-UV-absorbing impurities, nor does it define the nature of the contaminants. Mass spectrometry (MS) provides the essential second layer of verification. LC-MS or ESI-MS confirms that the observed mass matches the theoretical mass of the intended sequence, identifying common synthesis failure modes such as deletion sequences, incomplete deprotection, oxidation (+16 Da), and diastereomer formation.

What 95%, 98%, and 99% Actually Compare

A 95% result leaves roughly one part in twenty as non-target material, while a 99% result leaves one part in a hundred. In practice, this difference is critical at working concentrations: the absolute amount of contaminating sequence per assay scales with the purity gap, increasing the risk that an impurity with its own biological activity interferes with your experimental readout.

Purity figures also become more complex as chain length increases. A 40-residue peptide has significantly more sites for deletion and incomplete coupling than a five-residue fragment. Consequently, 98% area on a long sequence represents a vastly different impurity profile than 98% on a short fragment.

Purity vs. Peptide Content

Purity describes the composition of the peptide-related material present. Peptide content, however, describes how much of the total vial mass is actually peptide. The remainder is typically water, residual purification solvent, and the counterion—often acetate or trifluoroacetate—paired to the peptide's charges. A vial with 99% HPLC purity and 80% peptide content is not a contradiction; it is a standard chemical reality. Any gravimetric calculation built on label weight alone will inherit this factor, potentially leading to dosing errors.

Reading a Certificate of Analysis (COA)

A credible COA is a batch record, not a marketing document. When reviewing your documentation, ensure it includes:

• Batch Number: Must match the vial in your hand. A COA that cannot be tied to a specific lot documents nothing about your material.
• Method and Column: The gradient, chemistry, and wavelength determine whether the separation could have resolved likely impurities.
• Purity with Method: Area percent at a stated wavelength, not a rounded marketing figure.
• Mass Confirmation: Theoretical versus observed mass is the fastest way to catch a mislabelled compound.
• Appearance: A white lyophilized cake is standard; discoloration or gummy residue may suggest degradation or residual solvent.
• Date of Analysis: Purity at release is not necessarily purity after two years on a shelf.

For further guidance, our COA reading guide details each field, while our HPLC versus LC-MS article explains the limitations of each method.

Batch Consistency Outranks a Single High Number

For reproducibility, the most important question is whether the next vial behaves like the last. A 97% material with a stable, documented impurity profile across batches is a better experimental constant than a 99.5% material whose profile shifts with every purification run. This is why batch traceability is central to our documentation, and why results are published per batch rather than as a site-wide claim.

What We Publish for Every Compound

Each lot carries a unique batch number, an HPLC purity result, and mass confirmation, all published in our lab results archive. Our testing methodology page explains our analytical workflow, and individual product pages—such as Ipamorelin or GHK-Cu—link directly to their specific batch documentation.

A Practical Buying Checklist

• Request the COA for the exact batch you are receiving, not a generic sample document.
• Confirm purity is stated with its method and includes mass confirmation.
• Compare two or three batches before locking a protocol to one supplier.
• Record batch numbers in your lab notebook so anomalous results can be traced.
• Treat any supplier who cannot link documentation to a specific lot number as unverified.